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• LVHN does not have an established list of criteria to 
determine which Head and Neck Cancer (HNC) 
Patients undergoing Chemoradiotherapy (CRT) 
receive a Prophylactic Feeding Tube (PFT)
• NCCN guidelines recommend against placement of 
PFT in patients who have low Performance Status 
score (ECOG) unless they have severe pretreatment 
weight loss or severe dysphagia
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• Sample size n= 84
• Of the 84 patients, 56 (66.7%) received a PFT and 28 
(33.3%) did not 
• The majority of patients who received a PFT 
underwent cisplatin weekly as chemotherapy regimen 
• Most patients who received PFT had an initial ECOG 
score of 0 or 1, pretreatment dysphagia, and 
insignificant On-Treat Visit (OTV) weight loss 
• Patients who received PFT had lower weight loss 
percentage during and after treatment compared to 
patients with a RFT and no FT
• 91% of patients with PFTs used them
• Regardless of disease location, ECOG, BMI, 
nodal involvement, and tumor status, placement of 
PFT appears preferred in order to reduce need for 
subsequent RFT placement
• ECOG score does not determine need for PFT
• Even patients with initially low ECOG scores of 0-
1 benefited from PFT and reduced overall weight 
loss 
• Weekly cisplatin may have a lower anticipated 
degree of toxicity, however does not seem to 
increase likelihood of not benefitting from PFT 
• Patients with PFT had less weight loss likely 
indicating better overall nutrition status
Identify patients diagnosed with HNC between 2016 and 2019
Screen patient charts by inclusion criteria: stage III or IV HNC, 
chemotherapy and radiation treatment (CRT), treated at LVHN 
Cedar Crest or Muhlenberg sites, over 18 years of age
Collect patient information through EPIC and enter into REDcap
Perform statistical analysis to compare PFT with reactive 
feeding tube (RFT) and no FT
• Perform complete statistical analysis to find 
statistically significant results 
• Evaluate if patients with both PFTs and RFTs were 
relying upon them fully or using them as 
supplementation
• Compare the treatment “failure” of a RFT with the 
treatment “failure” of receiving a PFT and not using 
it 
• Track outpatient hydration appointments of 
patients with no FT 
• Use data to develop concrete guide to help 
physicians determine which patients will benefit 
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Cancer Support Services 
Objectives
• Identify common characteristics found in patients who 
had PFT placed 
• Evaluate weight loss, hospital admissions, and 
Feeding Tube (FT) use to determine if PFT improved 
patient outcomes 
• Ultimately create guideline for physicians to help 
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Figure 1: Chemotherapy Regime of PFT 
patients vs Non-PFT patients 
Figure 2: ECOG scores of PFT 
patients vs Non-PFT patients 
Figure 3: Pretreatment Dysphagia of PFT 
patients vs Non-PFT patients 
Figure 4: Significant OTV Weight Loss of 
PFT patients vs Non-PFT patients 
Figure 5: Weight Change Percent by FT Groups 
